Benzinga | May 12, 2021 07:04AM EDT

Chemomab to Present at Oppenheimer's Virtual Rare And Orphan Disease Summit May 21

Chemomab Therapeutics Ltd. (NASDAQ:CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the company's CEO, Dr. Adi Mor will present a corporate update at Oppenheimer's virtual Rare and Orphan Disease Summit on May 21st, 2021.

Webcast link may be accessed here.

The presentation will be available for 30 days following the event on the Company's investors section at the Chemomab website.